End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 SEK | -.--% | -.--% | +3.45% |
05-07 | PEPTONIC medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-17 | Peptonic Medical Plans SEK61 Million Shares, Warrants Issue | MT |
Business Summary
Number of employees: 32
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Self-diagnostic Rapid Tests and Self-care Treatments
100.0
%
| 44 | 100.0 % | 37 | 100.0 % | -14.93% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 44 | 100.0 % | 37 | 100.0 % | -14.93% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Erik Sundquist
CEO | Chief Executive Officer | 54 | 13/04/21 |
Albert Lindgren
DFI | Director of Finance/CFO | - | 20/10/23 |
Hadar Kessary
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | 64 | 31/12/08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Tarek Shoeb
BRD | Director/Board Member | 55 | 23/05/23 |
Karl Blom
BRD | Director/Board Member | 55 | - |
Anders Norling
BRD | Director/Board Member | 58 | 23/05/22 |
Daniel Rudeklint
BRD | Director/Board Member | 43 | - |
Anna Stinger
BRD | Director/Board Member | - | 23/05/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,534,845,596 | 114,705,799 ( 7.473 %) | 0 | 7.473 % |
Company contact information
Peptonic Medical AB
Gustavslundsvägen 143
167 51, Bromma
+46 8 53 02 01 10
http://www.peptonicmedical.seSector
1st Jan change | Capi. | |
---|---|---|
+3.45% | 8.48M | |
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- PMED Stock
- Company PEPTONIC medical AB